MindWalk Holdings (HYFT) Fundamentals 2026 — Revenue Analysis | SniperIQ
MindWalk Holdings (HYFT) is a US-listed Healthcare company in Biotechnology with a market capitalization of $69M, trading at
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is MindWalk Holdings's market cap?
MindWalk Holdings (HYFT) has a market capitalization of approximately $69M, trading at
What is MindWalk Holdings's P/E ratio?
MindWalk Holdings's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 6.4x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is MindWalk Holdings?
MindWalk Holdings runs a net profit margin of -66.4%, a gross margin of 60.3%, and an operating margin of -65.3%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does MindWalk Holdings generate?
MindWalk Holdings reported revenue of CAD 25M for fiscal year 2025, with net income of -CAD 30M and earnings per share (EPS) of -0.9. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does MindWalk Holdings pay a dividend?
MindWalk Holdings does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is MindWalk Holdings financially healthy?
MindWalk Holdings carries a debt-to-equity ratio of 0.24x and a current ratio of 3.74x, with a market beta of 0.83. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is MindWalk Holdings a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For MindWalk Holdings (HYFT) the key facts are: market cap $69M, revenue CAD 25M, 52-week range 0.99-3.246. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track MindWalk Holdings's full fundamentals live
Get MindWalk Holdings's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.